Filing Overview
Jin Medical International Ltd. filed a Form 6-K for February 2024 on February 1, 2024. The filing reports the results of the extraordinary general meeting of shareholders held on January 30, 2024.
Business Context and Reporting Period
The filing concerns a corporate capital-structure action rather than operating or financial results. The Company is a foreign private issuer headquartered in Changzhou, Jiangsu Province, China, and files annual reports on Form 20-F.
Financial and Capital Metrics
- 7,827,355 ordinary shares were outstanding as of the January 12, 2024 record date.
- Shareholders representing 6,234,204 shares attended in person or by proxy, equal to approximately 79.65% of outstanding shares.
- The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating-performance metrics.
Material Corporate Action
Shareholders approved a subdivision of each issued and unissued ordinary share with a par value of US$0.001 into 20 ordinary shares with a par value of US$0.00005 each. The subdivision is to become effective on a date determined by a director, no later than March 31, 2024.
Following the subdivision, the authorized share capital will be US$50,000 divided into 1,000,000,000 shares with a par value of US$0.00005 each. The action increases the number of authorized and issued shares without changing the stated authorized share capital.
Vote Results and Outlook
- Votes for: 6,234,204.
- Votes against: 118.
- Votes abstained: 0, as presented in the filing.
- The quorum requirement, which exceeded one-third of shares outstanding and entitled to vote, was satisfied.
The filing provides no financial guidance, operating outlook, management forecast, new risk disclosure, contingency, or unusual operating item.
Investor Verification Items
- Verify the effective date and completion of the 20-for-1 share subdivision.
- Confirm the post-subdivision number of issued and outstanding shares and the corresponding share-count adjustments for any securities.
- Confirm the vote table and resulting share counts in the filed exhibit or SEC record, including the reported abstention figure.
- Review subsequent filings for changes in capitalization, trading information, or financing activity following the subdivision.